Anticancer Bioscience
Latest round
- Angel
Last raised
- Jan 2026
Total raised
- $11M
Investors
- 2
About Anticancer Bioscience
, trading as Anticancer Bioscience, is a precision oncology drugs company that focuses on applying synthetic lethal approaches to develop targeted cancer therapies. It was named as a finalist for the Scrip Awards in the category of China Biopharma Leadership in 2022. Dun Yang, the founder, President and CEO of the company, used to work in the laboratory of Nobel Laureate J.D. The company has branch offices in St Andrews, San Francisco, Sydney, and Hyderabad. The company's main product category is anti-cancer drugs. The Company has technology platforms such as chemical compound library, small molecule libraries, natural product libraries, and other technology platforms, which are used for precision lethal oncology drug discovery and development of cancer therapies. The products have served cancer patients. The company generates revenue by doing R&D, and providing new anti-cancer drugs and cancer therapies.
Who invested in Anticancer Bioscience
2 investors across 2 rounds
See all investors in Anticancer Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Anticancer Bioscience
Who invested in Anticancer Bioscience?
Anticancer Bioscience has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anticancer Bioscience raised?
Anticancer Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Anticancer Bioscience last raise money?
Anticancer Bioscience's most recent round on record is a Angel, in Jan 2026.
What does Anticancer Bioscience do?
, trading as Anticancer Bioscience, is a precision oncology drugs company that focuses on applying synthetic lethal approaches to develop targeted cancer therapies.
Where is Anticancer Bioscience headquartered?
Anticancer Bioscience is headquartered in Chengdu, China.
Which VCs invest in companies like Anticancer Bioscience?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Anticancer Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Anticancer Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.